Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Scandinavian Pharma Products ApS
APS
Dissolved
CVR 37380296
Virklund Skolesti 9
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2016
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK 101K
-55% vs 2018
EBITDA margin
-19.0%
-114% vs 2018
Equity ratio
62.2%
Financial strength
Net profit 2019
DKK -17K
-117% vs 2018
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
DKK 101K
-55%
EBITDA
DKK -19K
-114%
Net profit
DKK -17K
-117%
Total assets
DKK 463K
+1%
Equity
DKK 288K
-6%
Employees
—
—
Company information
Legal name
Scandinavian Pharma Products ApS
CVR number
37380296
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. januar 2016
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af Anette Stilling Jensen.
Contact
Address
Virklund Skolesti 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Silkeborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
Income statement
DKK thousands
Item
2016
2017
2018
2019
Revenue
—
324
224
101
Staff expenses
-0
-60
-90
-120
EBITDA
-3
264
134
-19
Depreciation & amort.
-0
-0
-0
-0
EBIT
-3
264
134
-19
Net financials
0
-0
-3
-2
Profit before tax
-3
264
131
-21
Tax
-1
58
29
-4
Net profit
-3
206
101
-17
Balance sheet
DKK thousands
Item
2016
2017
2018
2019
Total assets
118
606
460
463
Equity
97
303
305
288
Long-term debt
0
0
0
0
Short-term debt
21
303
155
175
Total debt
21
303
155
175
Financial ratios
5-year trend
EBITDA margin
-19.0%
This company
15.8%
Market median
-220% vs market
2016
2019
Equity ratio
62.2%
This company
38.2%
Market median
+63% vs market
2016
2019
Return on equity
-5.8%
This company
18.4%
Market median
-132% vs market
2016
2019
Net profit margin
-16.7%
This company
8.1%
Market median
-306% vs market
2016
2019
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
2016
2019
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
2016
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-01-16 – 2016-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (2)
AS
Anette Stilling Jensen
Management
Management
2016 – 2021
LS
Li Sun
Management
Management
2016 – 2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
LMV Holding ApS
Company
50–66.65%
50–66.65%
2016
Hameo Holding ApS
Company
50–66.65%
50–66.65%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Scandinavian Pharma Products ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Anette Stilling Jensen
Management
0 companies
Li Sun
Management
0 companies